Biotechnologies offer immense promise to address complex problems facing society. However, as biotechnologies and the associated industry grow and evolve, so does the associated threat landscape. At times, the threat landscape is so complex and nebulous that individual companies often lack the resources to understand and mitigate threats. Public-private partnerships (PPP) offer proven models to bring companies together to address common, complex challenges. Therefore, we propose establishing a PPP—the BioEconomy Safety, Security, and Technology (BESST) Partnership—to aid industry in identifying and characterizing common threats and developing evidence-based risk mitigation strategies.

In biotech, we have the opportunity to leverage quality for more than just meeting regulations—we can use quality testing and controls to build trust, credibility, and a lasting competitive edge. Holding GMO products to the highest standards and communicating those standards can shift public perception, drive consumer confidence, and create new opportunities for innovation. With rigorous testing and a clear communication plan, prioritizing quality transforms not just our products, but the industry as a whole.

The bioeconomy is at a pivotal moment and has the potential to drive innovation that addresses global challenges. Yet, as the industry grows, so does its risk landscape. This panel explores how collaboration, competition, coordination, and cooperation can collectively safeguard the bioeconomy while fostering innovation. Industry leaders will discuss strategies to build trust, mitigate risks, and establish shared frameworks for safety and security. Join us to discuss how unified action can ensure the bioeconomy’s transformative potential is realized in a way that upholds safety, security, and efficiency.

Thought leadership opportunity to discuss the state of the U.S. bioeconomy, what we've learned over the last 2 years, and where we could possibly go in the future.